Antibody‐dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells

Anti‐ganglioside GD2 antibodies mainly work through antibody‐dependent cellular cytotoxicity (ADCC) and have demonstrated clinical benefit for children with neuroblastoma. However, high‐risk neuroblastoma still has a high recurrence rate. For further improvement in patient outcomes, ways to maximize...

Descripción completa

Detalles Bibliográficos
Autores principales: Mise, Naoko, Takami, Mariko, Suzuki, Akane, Kamata, Toshiko, Harada, Kazuaki, Hishiki, Tomoro, Saito, Takeshi, Terui, Keita, Mitsunaga, Tetsuya, Nakata, Mitsuyuki, Ikeuchi, Takayuki, Nakayama, Toshinori, Yoshida, Hideo, Motohashi, Shinichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814252/
https://www.ncbi.nlm.nih.gov/pubmed/26749374
http://dx.doi.org/10.1111/cas.12882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814252/
https://www.ncbi.nlm.nih.gov/pubmed/26749374
http://dx.doi.org/10.1111/cas.12882

Ejemplares similares